Acute gastroenteritis: From guidelines to real life

Clinical and Experimental Gastroenterology

Volumn 3, Issue 1, 2010, Pages 97-112

  Chow, Chung M ^a   Leung, Alexander K C ^b   Hon, Kam L ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antiemetic; Gastroenteritis; Guideline; Intravenous therapy; Ondansetron; Oral rehydration therapy; Rotavirus; Vomiting

Indexed keywords

ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE; DIMENHYDRINATE; DOLASETRON MESILATE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; GRANISETRON; MEPYRAMINE; METOCLOPRAMIDE; ONDANSETRON; PENTOBARBITAL; PLACEBO; PROCHLORPERAZINE; PROMETHAZINE; RAMOSETRON; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; TRIMETHOBENZAMIDE; TROPISETRON;

ACUTE GASTROENTERITIS; AGITATION; AKATHISIA; APNEA; BACTERIAL INFECTION; CENTRAL NERVOUS SYSTEM DEPRESSION; CENTRAL NERVOUS SYSTEM DISEASE; CHEMORECEPTOR; CHEMOTHERAPY INDUCED EMESIS; CHILD HOSPITALIZATION; CLINICAL TRIAL; CONSTIPATION; COUGHING; DEHYDRATION; DEPRESSION; DIARRHEA; DROWSINESS; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; GYNECOMASTIA; HALLUCINATION; HEART ARREST; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HOSPITALIZATION COST; HUMAN; HYPOTENSION; INNER EAR DISEASE; INTRAVENOUS ADMINISTRATION; MAXIMUM PLASMA CONCENTRATION; METHEMOGLOBINEMIA; MIGRAINE; MORNING SICKNESS; MORTALITY; MOTION SICKNESS; NAUSEA; NAUSEA AND VOMITING; NEUROLEPTIC MALIGNANT SYNDROME; OCULOGYRIC CRISIS; ORAL REHYDRATION THERAPY; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PHYSICIAN ATTITUDE; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE VOMITING; PRACTICE GUIDELINE; PROTOZOAL INFECTION; QT PROLONGATION; RADIATION SICKNESS; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; REVIEW; ROTAVIRUS INFECTION; SEDATION; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; TARDIVE DYSKINESIA; TORSADE DES POINTES; TREMOR; UNSPECIFIED SIDE EFFECT; VIRAL GASTROENTERITIS; VOMITING;

EID: 77955433594     PISSN: None     EISSN: 11787023     Source Type: Book Series    
DOI: 10.2147/ceg.s6554     Document Type: Review

References (130)

1. by-Payne J, Elliott E. Gastroenteritis in children. Clin Evid. 2004;12:443-454.
2. King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52(RR-16):1-16.
3. Santosham M. Oral rehydration therapy: reverse transfer of technology. Arch Pediatr Adolesc Med. 2002;156(12):1177-1179.
4. Glass RI, Kilgore PE, Holman RC, et al. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis. 1996;174(Suppl 1):S5-S11.
5. Ryan MJ, Ramsay M, Brown D, Gay NJ, Farrington CP, Wall PG. Hospital admissions attributable to rotavirus infection in England and Wales. J Infect Dis. 1996;(174 Suppl 1):S12-S18.
6. Carlin JB, Chondros P, Masendycz P, Bugg H, Bishop RF, Barnes GL. Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993-1996. Med J Aust. 1998;169(5):252-256.
7. Fang ZY, Yang H, Zhang J, et al. Child rotavirus infection in association with acute gastroenteritis in two Chinese sentinel hospitals. Pediatr Int. 2000;42(4):401-405.
8. Canadian Paediatric Society. Oral rehydration therapy and early refeeding in the management of childhood gastroenteritis. Paediatr Child Health. 2006;11(8):527-531.
9. Nelson EA, Tam JS, Bresee JS, et al. Estimates of rotavirus disease burden in Hong Kong: hospital-based surveillance. J Infect Dis 2005;(192 Suppl 1):S71-S79.
10. Webb A, Starr M. Acute gastroenteritis in children. Aust Fam Physician. 2005;34(4):227-231.
11. Wilhelmi I, Roman E, Sanchez-Fauquier A. Viruses causing gastroenteritis. Clin Microbiol Infect. 2003;9(4):247-262.
12. Rivest P, Proulx M, Lonergan G, Lebel MH, Bedard L. Hospitalisations for gastroenteritis: the role of rotavirus. Vaccine. 2004;22(15-16):2013-2017.
13. Ehlken B, Laubereau B, Karmaus W, Petersen G, Rohwedder A, Forster J. Prospective population-based study on rotavirus disease in Germany. Acta Paediatr. 2002;91(7):769-775.
14. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9(5):565-572.
15. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006;12(2):304-6.
16. Leung AK, Kellner JD, Davies HD. Rotavirus gastroenteritis. Adv Ther. 2005;22(5):476-487.
17. Andreasi MS, Cardoso DD, Fernandes SM, et al. Adenovirus, calicivirus and astrovirus detection in fecal samples of hospitalized children with acute gastroenteritis from Campo Grande, MS, Brazil. Mem Inst Oswaldo Cruz. 2008;103(7):741-744.
18. Caracciolo S, Minini C, Colombrita D, Foresti I, Avolio M, Tosti G, et al. Detection of sporadic cases of Norovirus infection in hospitalized children in Italy. New Microbiol. 2007;30(1):49-52.
19. Fodha I, Chouikha A, Dewar J, Trabelsi A, Boujaafar N, Steele AD. Prevalence of adenovirus antigens in children presenting with acute diarrhoea. Med Trop (Mars). 2007;67(3):256-258.
20. Jakab F, Peterfai J, Meleg E, Banyai K, Mitchell DK, Szucs G. Comparison of clinical characteristics between astrovirus and rotavirus infections diagnosed in 1997 to 2002 in Hungary. Acta Paediatr. 2005;94(6):667-671.
21. Kapikian AZ. Viral gastroenteritis. JAMA. 1993;269(5):627-630.
22. Elliott EJ. Acute gastroenteritis in children. BMJ. 2007;334(7583): 35-40.
23. Parashar UD, Alexander JP, Glass RI. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-12):1-13.
24. Malek MA, Curns AT, Holman RC, et al. Diarrhea - and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006;117(6): 1887-1892.
25. Lee BP, Azimi PH, Staat MA, et al. Nonmedical costs associated with rotavirus disease requiring hospitalization. Pediatr Infect Dis J. 2005;24(11):984-988.
26. Chang HG, Glass RI, Smith PF, Cicirello HG, Holman RC, Morse DL. Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J. 2003;22(9):808-814.
27. Staat MA, Azimi PH, Berke T, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J. 2002;21(3):221-227.
28. Reis EC, Goepp JG, Katz S, Santosham M. Barriers to use of oral rehydration therapy. Pediatrics. 1994;93(5):708-711.
29. Ozuah PO, Avner JR, Stein RE. Oral rehydration, emergency physicians, and practice parameters: a national survey. Pediatrics. 2002;109(2):259-261.
30. Walker-Smith JA, Sandhu BK, Isolauri E, et al. Guidelines prepared by the ESPGAN Working Group on Acute Diarrhoea. Recommendations for feeding in childhood gastroenteritis. European Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 1997;24(5):619-620.
31. Practice parameter: the management of acute gastroenteritis in young children. American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Pediatrics. 1996;97(3):424-435.
32. World Health Organization. The treatment of diarrhoea. A manual for physicians and other senior health care workers, 4th rev edn. World Health Organization. 2005; Available from: http://whqlibdoc.who.int/publications/2005-9241593180.pdf.
33. Hartling L, Bellemare S, Wiebe N, Russell K, Klassen TP, Craig W. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev. 2006;3:CD004390.
34. Bern C, Martines J, de Z, I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ. 1992;70(6):705-714.
35. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003;81(3):197-204.
36. Avery ME, Snyder JD. Oral therapy for acute diarrhea. The underused simple solution. N Engl J Med. 1990;323(13):891-894.
37. Sandhu BK, Isolauri E, Walker-Smith JA, et al. A multicenter study on behalf of the European Society of Paediatric Gastroenterology and Nutrition Working Group on Acute Diarrhoea. Early f eeding in childhood gastroenteritis. J Pediatr Gastroenterol Nutr. 1997;24(5): 522-527.
38. Elliott EJ, Backhouse JA, Leach JW. Pre-admission management of acute gastroenteritis. J Paediatr Child Health. 1996;32(1): 18-21.
39. Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for I mmunization. Arch Pediatr Adolesc Med. 2000;154(6):578-585.
40. Chow CM, Choi K, Nelson EA, et al. Use of intravenous fluids in Hong Kong children hospitalised for diarrhoea and relationship to severity and aetiology. Vaccine. 2009;27 (Suppl 5):F55-F60.
41. Bender BJ, Ozuah PO, Crain EF. Oral rehydration therapy: is anyone drinking? Pediatr Emerg Care. 2007;23(9):624-626.
42. Borison HL, Wang SC. Physiology and pharmacology of vomiting. Pharmacol Rev. 1953;5(2):193-230.
43. Freedman SB, Fuchs S. Antiemetic therapy in pediatric emergency departments. Pediatr Emerg Care. 2004;20(9):625-633.
44. Wang SC, borison HL. The vomiting center; a critical e xperimental analysis. Arch Neurol Psychiatry. 1950;63(6):928-941.
45. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs. 2000;59(2):213-243.
46. Hockenberry-Eaton M, Benner A. Patterns of nausea and vomiting in children: nursing assessment and intervention. Oncol Nurs Forum. 1990;17(4):575-584.
47. Williams C. Causes and management of nausea and vomiting. Nurs Times. 1994;90(44):38-41.
48. Lundgren O, Peregrin AT, Persson K, Kordasti S, Uhnoo I, Svensson L. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science. 2000;287(5452):491-495.
49. Kordasti S, Sjovall H, Lundgren O, Svensson L. Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea. Gut. 2004;53(7):952-957.
50. Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111(Suppl 8A):106S-112S.
51. Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull. 1998;47(5): 395-406.
52. Flake ZA, Scalley RD, Bailey AG. Practical selection of antiemetics. Am Fam Physician. 2004;69(5):1169-1174.
53. Spinks AB, Wasiak J, Villanueva EV, Bernath V. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev. 2007;(3):CD002851.
54. Chisakuta AM, Mirakhur RK. Anticholinergic prophylaxis does not prevent emesis following strabismus surgery in children. Paediatr Anaesth. 1995;5(2):97-100.
55. Cubeddu LX, Trujillo LM, Talmaciu I, et al. Antiemetic activity of ondansetron in acute gastroenteritis. Aliment Pharmacol Ther. 1997;11(1):185-191.
56. Keller VE. Management of nausea and vomiting in children. J Pediatr Nurs. 1995;10(5):280-286.
57. Ernst AA, Weiss SJ, Park S, Takakuwa KM, Diercks DB. Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double-blind clinical trial. Ann Emerg Med. 2000;36(2): 89-94.
58. Li ST, DiGiuseppe DL, Christakis DA. Antiemetic use for acute gastroenteritis in children. Arch Pediatr Adolesc Med. 2003;157(5):475-479.
59. O'Loughlin EV, Notaras E, McCullough C, Halliday J, Henry RL. Home-based management of children hospitalized with acute g astroenteritis. J Paediatr Child Health. 1995;31(3): 189-191.
60. Nelson EA, Chow E, Lewindon PJ, Biswas R. Management of acute diarrhoea in Hong Kong. J Paediatr Child Health. 1997;33(4):360.
61. Kwon KT, Rudkin SE, Langdorf MI. Antiemetic use in pediatric gastroenteritis: a national survey of emergency physicians, pediatricians, and pediatric emergency physicians. Clin Pediatr (Phila). 2002;41(9):641-652.
62. Albano F, Bruzzese E, Spagnuolo MI, De MG. Antiemetics for children with gastroenteritis: off-label but still on in clinical practice. J Pediatr Gastroenterol Nutr. 2006;43(3):402-404.
63. Pfeil N, Uhlig U, Kostev K, et al. Antiemetic medications in children with presumed infectious gastroenteritis - pharmacoepidemiology in Europe and Northern America. J Pediatr. 2008;153(5): 659-662.
64. Cohen IT. An overview of the clinical use of ondansetron in preschool age children. Ther Clin Risk Manag. 2007;3(2):333-339.
65. Nahata MC, Hui LN, Koepke J. Efficacy and safety of ondansetron in pediatric patients undergoing bone marrow transplantation. Clin Ther. 1996;18(3):466-476.
66. Jurgens H, McQuade B. Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children. Oncology. 1992;49(4):279-285.
67. Langston WT, Wathen JE, Roback MG, Bajaj L. Effect of ondansetron on the incidence of vomiting associated with ketamine sedation in children: a double-blind, randomized, placebo-controlled trial. Ann Emerg Med 2008;52(1):30-4.
68. Scharman EJ. Use of ondansetron and other antiemetics in the management of toxic acetaminophen ingestions. J Toxicol Clin T oxicol. 1998;36(1-2):19-25.
69. Gruppo LQ, Jr. Intravenous Zofran for headache. J Emerg Med. 2006;31(2):228-229.
70. DeCamp LR, Byerley JS, Doshi N, Steiner MJ. Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis. Arch Pediatr Adolesc Med. 2008;162(9):858-865.
71. Stork CM, Brown KM, Reilly TH, Secreti L, Brown LH. Emergency department treatment of viral gastritis using intravenous ondansetron or dexamethasone in children. Acad Emerg Med. 2006;13(10):1027-1033.
72. Reeves JJ, Shannon MW, Fleisher GR. Ondansetron decreases v omiting associated with acute gastroenteritis: a randomized, controlled trial. Pediatrics. 2002;109(4):e62.
73. Ramsook C, Sahagun-Carreon I, Kozinetz CA, Moro-Sutherland D. A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med. 2002;39(4):397-403.
74. Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med. 2006;354(16):1698-1705.
75. Roslund G, Hepps TS, McQuillen KK. The role of oral ondansetron in children with vomiting as a result of acute gastritis/gastroenteritis who have failed oral rehydration therapy: a randomized controlled trial. Ann Emerg Med. 2008;52(1):22-29.
76. Alhashimi D, Al-Hashimi H, Fedorowicz Z. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev. 2009;(2):CD005506.
77. Yilmaz HL, Yildizdas RD, Sertdemir Y. Clinical trial: Oral ondansetron for reducing vomiting secondary to acute gastroenteritis in children - a double-blind randomised study. Aliment Pharmacol Ther. 2010;31(1):82-91.
78. Bryson JC. Clinical safety of ondansetron. Semin Oncol. 1992;19(6 Suppl 15):26-32.
79. Finn AL. Toxicity and side effects of ondansetron. Semin Oncol. 1992;19(4 Suppl 10):53-60.
80. Roila F, Del FA. Ondansetron clinical pharmacokinetics. Clin Pharmacokinet. 1995;29(2):95-109.
81. Culy CR, Bhana N, Plosker GL. Ondansetron: a review of its use as an antiemetic in children. Paediatr Drugs. 2001;3(6):441-479.
82. Scuderi PE. Pharmacology of antiemetics. Int Anesthesiol Clin. 2003;41(4):41-66.
83. Forni C, Ferrari S, Loro L, et al. Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusions. Support Care Cancer. 2000;8(2): 131-133.
84. Orchard PJ, Rogosheske J, Burns L, et al. A prospective randomized trial of the antiemetic efficacy of ondansetron and granisetron during bone marrow transplantation. Biol Blood Marrow Transplant. 1999;5(6):386-393.
85. Karamanlioglu B, Turan A, Memis D, Sut N. Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children. Eur J Anaesthesiol. 2003;20(10): 831-835.
86. Olutoye O, Jantzen EC, Alexis R, Rajchert D, Schreiner MS, Watcha MF. A comparison of the costs and efficacy of ondansetron and dolasetron in the prophylaxis of postoperative vomiting in pediatric patients undergoing ambulatory surgery. Anesth Analg. 2003;97(2): 390-396.
87. Sukhani R, Pappas AL, Lurie J, Hotaling AJ, Park A, Fluder E. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children. Anesth Analg. 2002;95(5):1230-1235.
88. De NP, Ivani G. Management of postoperative nausea and vomiting in children. Paediatr Drugs. 2002;4(11):717-728.
89. Marill KA, Walsh MJ, Nelson BK. Intravenous Lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial. Ann Emerg Med. 2000;36(4): 310-319.
90. McCall JE, Stubbs K, Saylors S, et al. The search for cost-effective p revention of postoperative nausea and vomiting in the child undergoing reconstructive burn surgery: ondansetron versus dimenhydrinate. J Burn Care Rehabil. 1999;20(4):309-315.
91. Schlager A, Mitterschiffthaler G, Puhringer F. Rectally administered dimenhydrinate reduces postoperative vomiting in children after strabismus surgery. Br J Anaesth. 2000;84(3):405-406.
92. Welters ID, Menges T, Graf M, Beikirch C, Menzebach A, Hempelmann G. Reduction of postoperative nausea and vomiting by dimenhydrinate suppositories after strabismus surgery in children. Anesth Analg. 2000;90(2):311-314.
93. Uhlig U, Pfeil N, Gelbrich G, et al. Dimenhydrinate in children with infectious gastroenteritis: a prospective, RCT. Pediatrics. 2009;124(4):e622-e632.
94. Tibbs RC. A clinical comparison of rectal pyrilamine maleate and trimethobenzamide hydrochloride for the control of vomiting in children. J Miss State Med Assoc. 1969;10(4):130-132.
95. Hickson GB, Altemeier WA, Clayton EW. Should promethazine in liquid form be available without prescription? Pediatrics. 1990;86(2):221-225.
96. Cote CJ, Karl HW, Notterman DA, Weinberg JA, McCloskey C. Adverse sedation events in pediatrics: analysis of medications used for sedation. Pediatrics. 2000;106(4):633-644.
97. Starke PR, Weaver J, Chowdhury BA. Boxed warning added to promethazine labeling for pediatric use. N Engl J Med. 2005;352(25):2653.
98. Leung AK, Robson WL. Acute gastroenteritis in children: role of antiemetic medication for gastroenteritis-related vomiting. Paediatr Drugs. 2007;9(3):175-184.
99. Van EM, Dhondt F, Heck E, Ameryckx L, Van RH. A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children. Postgrad Med J. 1979;55(Suppl 1):36-39.
100. Casteels-Van DM, Jaeken J, Van der SP, Van den BP. Dystonic reactions in children caused by metoclopramide. Arch Dis Child. 1970;45(239):130-133.
101. Batts KF, Munter DW. Metoclopramide toxicity in an infant. Pediatr Emerg Care. 1998;14(1):39-41.
102. Langford JS, Sheikh S. An adolescent case of sulfhemoglobinemia associated with high-dose metoclopramide and N-acetylcysteine. Ann Emerg Med. 1999;34(4 Pt 1):538-541.
103. Madani S, Tolia V. Gynecomastia with metoclopramide use in pediatric patients. J Clin Gastroenterol. 1997;24(2):79-81.
104. Wilson CM, Bird SG, Bocash W, Yang LL, Merritt RJ. Methemoglobinemia following metoclopramide therapy in an infant. J Pediatr Gastroenterol Nutr. 1987;6(4):640-642.
105. Blanc VF, Ruest P, Milot J, Jacob JL, Tang A. Antiemetic prophylaxis with promethazine or droperidol in paediatric outpatient strabismus surgery. Can J Anaesth. 1991;38(1):54-60.
106. Fassoulaki A, Galanaki E. The antiemetic effect of droperidol: is it dose dependent? Acta Anaesthesiol Belg. 1989;40(3):179-182.
107. Verheecke G, Troch E. Oral droperidol for premedication in children. Acta Anaesthesiol Belg 1985 Dec;36(4):421-6.
108. Olutoye O, Watcha MF. Management of postoperative vomiting in pediatric patients. Int Anesthesiol Clin. 2003;41(4):99-117.
109. Joshi PT, Hamel L, Joshi AR, Capozzoli JA. Use of droperidol in hospitalized children. J Am Acad Child Adolesc Psychiatry. 1998;37(2):228-230.
110. Bailey P, Norton R, Karan S. The FDA droperidol warning: is it justified? Anesthesiology. 2002;97(1):288-289.
111. Nuttall GA, Eckerman KM, Jacob KA, et al. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population? Anesthesiology. 2007;107(4):531-536.
112. Jacoby JL, Fulton J, Cesta M, Heller M. After the black box warning: dramatic changes in ED use of droperidol. Am J Emerg Med 2005;23(2):196.
113. Dhondt F, Traen S, VanEygen M, Baran D, Willaert H. Domperidone (R-33812) suppositories: an effective antiemetic agent in diverse pediatric conditions: multicenter trial. Curr Ther Res Clin Exp. 1978;24(8):912-923.
114. Extrapyramidal reactions due to domperidone. Lancet. 1980;2(8198):802.
115. Weaving A, Bezwoda WR, Derman DP. Seizures after antiemetic treatment with high dose domperidone: report of four cases. Br Med J (Clin Res Ed). 1984;288(6432):1728.
116. Bonuccelli U, Nocchiero A, Napolitano A, et al. Domperidone-induced acute dystonia and polycystic ovary syndrome. Mov Disord. 1991;6(1):79-81.
117. Lankamp DJ, Willemse J, Pikaar SA, van Heyst AN. Prochlorperazine in childhood: side-effects. Clin Neurol Neurosurg. 1977;80(4):264-271.
118. Ordog GJ, Vann PW, Owashi ND, Wasserberger J, Herman LS, Balasubramaniam S. Intravenous prochlorperazine for the rapid control of vomiting in the emergency department. Ann Emerg Med. 1984;13(4):253-258.
119. Bardfeld PA. A controlled double-blind study of trimethobenzamide, prochlorperazine, and placebo. JAMA. 1966;196(9):796-798.
120. Drotts DL, Vinson DR. Prochlorperazine induces akathisia in emergency patients. Ann Emerg Med. 1999;34(4 Pt 1):469-475.
121. Olsen JC, Keng JA, Clark JA. Frequency of adverse reactions to prochlorperazine in the ED. Am J Emerg Med. 2000;18(5):609-611.
122. Baker FM, Cook P. Compazine complications: a review. J Natl Med Assoc. 1981;73(5):409-412.
123. Bejar JM. Compazine-induced dyskinesia in a 14-month-old boy. Clin Neuropharmacol. 1984;7(2):171-172.
124. Ginsburg CM, Clahsen J. Evaluation of trimethobenzamide hydrochloride (Tigan) suppositories for treatment of nausea and vomiting in children. J Pediatr. 1980;96(4):767-769.
125. FDA halts sales of some anti-vomiting suppositories ... and are cough medications effective in children? Child Health Alert. 2007;25:1-2.
126. Sanger GJ, Andrews PL. Treatment of nausea and vomiting: gaps in our knowledge. Auton Neurosci. 2006;129(1-2):3-16.
127. Markman M, Sheidler V, Ettinger DS, Quaskey SA, Mellits ED. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med. 1984;311(9):549-552.
128. Gavagan T, Schumann SA. This antiemetic may help kids skip that trip to the hospital. J Fam Pract. 2009;58(2):85-88.
129. Guarino A, Albano F, Ashkenazi S, et al. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr. 2008;46(Suppl 2):S81-S122.
130. Szajewska H, Hoekstra JH, Sandhu B. Management of acute gastroenteritis in Europe and the impact of the new recommendations: a multicenter study. The Working Group on acute Diarrhoea of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2000;30(5):522-527.